WALTHAM, Mass.—BVI, a diversified global ophthalmic device company, announced an investment in Beyeonics Vision, a medical technology subsidiary of Elbit Systems Ltd. (NASDAQ: ESLT and TASE: ESLT). Beyeonics Vision uses integrated augmented reality, tracking, and image processing/AI platforms to deliver improved visualization, optimized workflow, and real-time support to surgeon decision-making process in the operating room. The collaboration also promotes a streamlined process to commercialize Beyeonics One in the United States, with potential for rapid expansion in territories outside of the United States.

Beyeonics Vision has been developing Beyeonics One, a commercial ophthalmic digital imaging system designed to replace optical analog microscopes. The company describes Beyeonics One as “an open and upgradable digital visualization platform.” It is equipped with an ultra-high-resolution camera that processes and transfers digitally enhanced images to a high-resolution head-wearable display for “a truly immersive and natural stereoscopic 3-D viewing experience,” according to Beyeonics Vision. Beyeonics One provides surgeons with enhanced automation, programming autonomy and more freedom to set-up the operating room and adopt a more ergonomically efficient posture. Additionally, the system enables real-time decision-making process with customizable integration of accessible pre-/intra-operative data and seamless integration with other devices, the company said.
 
“We are excited to partner with BVI on the U.S. commercialization of Beyeonics One and the potential to collaborate on future innovations as well. Through this collaboration we aim to expand our collective capabilities to optimize all aspects of visualization for eye surgeons and offer a transformative experience to providers and patients,” said Ron Schneider, CEO of Beyeonics Vision.
 
BVI first previewed their partnership with Beyeonics Vision at the American Society of Cataract and Refractive Surgery annual meeting in July 2021 and will continue this at ESCRS in Amsterdam in October, and AAO in New Orleans in November.